Organization Overview
Historical Acquisition Tree
Alternative names
Key: Inovio Pharmaceuticals (18) Acquired (2)
Key: Inovio Pharmaceuticals (35) Acquired (1)
Acquired Immunodeficiency Syndrome (Phase 2)
Anus Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma in Situ (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cervical Intraepithelial Neoplasia (Phase 3)
Communicable Diseases (Phase 1)
Coronavirus Infections (Phase 3)
Dengue (Phase 1)
Glioblastoma (Phase 2)
Hematologic Neoplasms (Phase 2)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis B (Phase 1)
Hepatitis B, Chronic (Phase 1)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Hepatitis, Chronic (Phase 2)
HIV Infections (Phase 2)
Infections (Phase 1)
Influenza, Human (Phase 1)
Influenza in Birds (Phase 1)
Lassa Fever (Phase 1)
Leukemia (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Squamous Cell (Phase 2)
Orthomyxoviridae Infections (Phase 1)
Papilloma (Phase 2)
Papillomavirus Infections (Phase 2)
Penile Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Recurrence (Phase 2)
Respiratory Tract Diseases (Phase 1)
Respiratory Tract Infections (Phase 2)
RNA Virus Infections (Phase 1)
Severe Acute Respiratory Syndrome (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Uterine Cervical Dysplasia (Phase 3)
Uterine Cervical Neoplasms (Phase 2)
Vaginal Neoplasms (Phase 2)
Virus Diseases (Phase 2)
Vulvar Neoplasms (Phase 2)